Thus, GPR81 inhibition may constitute a factual anticancer approach, since lactate is the main metabolite exported, through monocarboxylate transporters (MCTs), from glycolytic cancer cells, supporting both microenvironmental acidosis and GPR81-mediated signaling [27]. This evidence concerns the gene HCAR1 and cancer.